Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial [Phase 2]
Phase 2 randomized trial evaluating add-on dapagliflozin for patients with type 2 diabetes and heart failure with reduced ejection fraction …
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: A Multi-center 12-week Study of HMS5552 in T2DM [Phase 2]
Phase 2 clinical trial update for HMS5552 in type 2 diabetes completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Observational study completed to understand challenges in progression of insulin therapy for type 2 diabetes; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: Oat Beta-glucan as a Supplement in Chilean Type 2 Diabetics [Phase 2]
Phase 2 trial evaluating oat beta-glucan as a supplement in Chilean patients with Type 2 diabetes has been completed.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Veterans Inpatient Insulin Study and Transition to Outpatient Therapy [Phase 4]
Phase 4 trial on inpatient insulin strategy transitioning to outpatient therapy in type 2 diabetes mellitus completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects [Phase 2]
Phase 2 trial evaluating TLR4 inhibition in obese and type 2 diabetic subjects completed; results posted after termination.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Effect of Anti-diabetic Drugs on Glycemic Variability [Phase 4]
Phase 4 clinical trial update evaluating the effect of anti-diabetic drugs on glycemic variability in adults with type 2 diabetes.
-
FDA approval · 2020-03-03FDA Approved: METFORMIN HYDROCHLORIDE ORAL SOLUTION — Original Application (TRUPHARMA, LLC)
FDA approved a generic metformin hydrochloride oral solution from TRUPHARMA, LLC as an Original ANDA, expanding available metformin formulat…
-
FDA approval · 2020-02-28FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for BYETTA (exenatide) submitted by AstraZeneca Pharmaceuticals LP. The approval updates the product…
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing oral semaglutide to sitagliptin in adults with type 2 diabetes; study completed with posted results, focusing on eff…
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating cardiovascular safety of oral semaglutide in adults with type 2 diabetes has completed with results posted.
-
CLINICAL_TRIALS research · 2020-02-27Clinical Trial Update: Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents [Phase 4]
Phase 4 clinical trial evaluating how gut microbiota responds to hypoglycemic agents in type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: PK/PD Study of U-500 Regular Insulin [Phase 2]
Phase 2 PK/PD study of U-500 regular insulin in patients with Type 2 diabetes and high insulin requirements completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: Perioperative Continuation of Metformin Therapy in Patients With Typ 2 Diabetes Mellitus Undergoing Non-cardiac Surgery [Phase 4]
Phase 4 trial update evaluating perioperative continuation of metformin in patients with type 2 diabetes undergoing non-cardiac surgery.
-
CLINICAL_TRIALS withdrawal · 2020-02-25Clinical Trial Update: Empaglifozin in Early Diabetic Kidney Disease [Phase 3]
Phase 3 trial of empagliflozin in early diabetic kidney disease was withdrawn.
-
FDA approval · 2020-02-21FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Trulicity (dulaglutide) submitted by Eli Lilly. The approval reflects a change to the product's …
-
FDA approval · 2020-02-21FDA Approved: PIOGLITAZONE HCL AND METFORMIN HCL — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for Pioglitazone HCl and Metformin HCl, a fixed-dose combination pro…
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of dual add-on therapy with gemigliptin and dapagliflozin to metformin in type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Physical Activity Behavior Change for Older Adults After Dysvascular Amputation [NA]
A completed clinical trial evaluating physical activity behavior change for older adults after dysvascular amputation, with results posted i…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment [Phase 3]
Phase 3 trial comparing oral semaglutide to placebo in adults with type 2 diabetes and moderate renal impairment, reporting efficacy and saf…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus. [Phase 3]
Phase 3 trial comparing oral semaglutide with flexible dose adjustment to sitagliptin in adults with type 2 diabetes; completed with posted …
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only [Phase 3]
Phase 3 trial comparing oral semaglutide to placebo in type 2 diabetes patients managed with diet and exercise shows efficacy and safety res…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Impact of Empaglifozine on Cardiac Ectopic Fat [Phase 3]
Phase 3 trial update evaluating empagliflozin on cardiac ectopic fat in type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Starter Kit Study in Insulin naïve Patients [Phase 2, Phase 3]
Phase 2/3 trial update for a starter kit study in insulin‑naïve patients with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: New Patient Support Program in Type 2 Diabetes
A completed clinical trial in type 2 diabetes evaluating a new patient support program; results posted in 2020.